Clinical Trial Update: The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether Ginkgo Biloba Extract protects against cisplatin-induced ototoxicity in humans has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss
• Ototoxicity

Drugs mentioned

• CISPLATIN (cisplatin)
• Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: University of Brasilia | Conditions: Ototoxicity, Hearing Loss | Phase 2 | Status: COMPLETED